Stay updated with breaking news from Chris Ehrlich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- ProLynx, Inc., a biotechnology company with a novel platform technology for half-life extension of therapeutics, enabling novel and potentially best-in-class
ProLynx appoints Richard King as Chief Executive Officer and Chris Ehrlich as Board Director
Join us as a panel of AI industry experts discuss – over Twitter – key strategies for expanding your company's AI usage.
Join us on January 18 at 11 AM PT, when @eWEEKNews hosts its monthly #eWEEKChat. The topic will be “Digital Transformation Trends."
26.08.2021 - Common stock and warrants expected to commence trading on Nasdaq on August 26, 2021 under the ticker symbols EFTR and EFTRWSAN DIEGO, Aug. 25, 2021 (GLOBE NEWSWIRE) - eFFECTOR Therapeutics, Inc. (eFFECTOR), a leader in the development of selective ... Seite 1